Encainide

Encainide
Clinical data
Trade names Enkaid
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a605040
ATC code C01BC08 (WHO)
Legal status
Legal status
  • Withdrawn
Identifiers
CAS Number 66778-36-7 YesY
PubChem (CID) 48041
DrugBank DB01228 YesY
ChemSpider 43697 YesY
UNII SY3J0147NB YesY
KEGG D07894 YesY
ChEBI CHEBI:4788 YesY
ChEMBL CHEMBL315838 N
Chemical and physical data
Formula C22H28N2O2
Molar mass 352.47 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.[1]

Synthesis

Encainide synthesis:[2][3][4]

See also

References

  1. Echt, D. S.; Liebson, P. R.; Mitchell, L. B.; Peters, R. W.; Obias-Manno, D.; Barker, A. H.; Arensberg, D.; Baker, A.; Friedman, L.; Greene, H. L.; Huther, M. L.; Richardson, D. W. (1991). "Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo". New England Journal of Medicine. 324 (12): 781–788. doi:10.1056/NEJM199103213241201. PMID 1900101.
  2. S.J. Dykstra, J.L. Minelli, DE 2210154 (1972).
  3. S.J. Dykstra, J.L. Minelli, U.S. Patent 3,931,195 (1976).
  4. Dykstra, Stanley J. (1973). "Lysergic acid and quinidine analogs. 2-(o-Acylaminophenethyl)piperidines". Journal of Medicinal Chemistry. 16 (9): 1015–1020. doi:10.1021/jm00267a012. PMID 4745503.


This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.